USask VIDO-InterVac expands international role to test antiviral compounds against COVID-19

Posted on

The Vaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac) at the University of Saskatchewan (USask) has been awarded a grant of almost $830,000 from the COVID-19 Therapeutics Accelerator to determine the effectiveness of several antiviral compounds against COVID-19….

https://www.vido.org/news/usask-vido-intervac-expands-international-role-to-test-antiviral-compounds-against-covid-19

Read More Impact Stories

Posted on

B.C. researchers identify gene that fuels aggressive childhood cancers

For patients with neuroblastoma, one of the most common solid tumours in children, disease outcomes can vary widely. Some children [...]
Read more
Posted on

Researchers develop first COVID-19 rapid test for wastewater

McMaster researchers have developed the first COVID rapid test for community wastewater, which will make early warning surveillance of infectious [...]
Read more
Posted on

World’s most comprehensive study on COVID-19 mental health

Study shows limited impact of pandemic on mental health, underlining strength of human resilience. COVID-19 has taken a relatively limited [...]
Read more
View All Impact Stories